CAS No. |
2250059-27-7 |
|---|---|
中文名称 |
RMC-4529(该名称为研发代号/商品代号,非IUPAC系统命名;仅凭代号无法生成符合CCS/IUPAC的无歧义中文系统命名,需提供完整英文系统命名或结构信息如SMILES/InChI) |
英文名称 |
RMC-4529 |
别名 |
RMC-4529 |
标准英文名 |
N-(4-(4-amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)-1-(4-(((((3S,5R,6R,7E,9R,10S,11E,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-((R)-1-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)propan-2-yl)-5,10,21-trimethoxy-6,8,12,14,20,26-hexamethyl-1,28,29-trioxo-1,3,4,5,6,9,10,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-11H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-11-ylidene)amino)oxy)methyl)-1H-1,2,3-triazol-1-yl)-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-amide |
分子式 |
C90H139N13O23 |
分子量 |
1771.17 |
精确分子量 |
1770.01 |
SMILES |
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)C[C@@H](OC)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)/C(=N/OCC2=CN(CCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCN3N=C(C4=CC5=C(C=C4)OC(N)=N5)C4=C(N)N=CN=C43)N=N2)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C |
标准SMILES |
CC1=C[C@@H](C)[C@@H](C[C@H](OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H](C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)/C(=N\OCC3=CN(CCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCN4N=C(C5C4=NC=NC=5N)C4=CC5N=C(N)OC=5C=C4)N=N3)/[C@H](OC)[C@@H]1O)CC[C@H]2C)[C@H](C)C[C@H]1C[C@@H](OC)[C@H](O)CC1)OC |
用途 |
RMC-4529 is used as an mTOR kinase inhibitor, demonstrating potent inhibition of p-4E-BP1 (T37/46) with an IC50 value of 1.0 nM in cellular assays. |
InChIKey |
PSGYEYPZNOWGNB-DTGDRGTPSA-N |
|
|
评论 |
|---|